A pathogen that can wait for weeks in silence on a bedrail is unsettling. Until it finds its way into someone who is already fighting for their life, there is no fever, no outward sign, and nothing to indicate that it is present at all. That is essentially the case with Candida auris, a drug-resistant fungus that the CDC has been monitoring with increasing alarm since it initially surfaced in the US in 2016. There were 48 cases reported at the time. That figure increased to over 6,000 by 2024.
Over 3,400 cases had been reported this year in 26 states as of late July 2026. With over 700 cases, Texas is in the lead, followed by Illinois and Michigan. Geographically, the numbers have also spread, appearing in locations that weren’t on the map a few years ago, from coastal states into the middle of the nation.
In 2009, a type of yeast called Candida auris was discovered in Japan. The way it behaves in medical environments sets it apart from the Candida species that physicians have long dealt with, the type responsible for common yeast infections. The antifungal drugs that doctors usually turn to don’t work on it consistently. Certain strains exhibit resistance to all three of the main classes of antifungal medications. When that occurs, the treatment toolkit is largely depleted. In the words of one epidemiologist at the University of South Carolina, “the patient is essentially on their own if the pathogen resists every available treatment.”
It is challenging to determine the exact death toll from C. auris, in part because so many afflicted patients are already very sick. According to CDC estimates, between 30 and 60 percent of individuals with C. auris infections have died; however, there is a disclaimer because many of these deaths are probably due to underlying conditions. Nevertheless, it’s a figure that causes discomfort in the mind.
The fungus mainly spreads between patients in hospitals and long-term care facilities thru contaminated surfaces, shared medical equipment, IV lines, catheters, and breathing tubes. It can live for weeks on surfaces. One of the reasons containment is so challenging is that standard disinfectants don’t always work against it. The primary lines of defense at the moment, according to infectious disease specialists at Vanderbilt and UC San Francisco, are promptly identifying infected patients, isolating them, using the appropriate disinfectants, and making sure that stringent hand hygiene procedures are followed.
It’s important to understand who is truly in danger. There is very little chance that C. auris will cause serious illness in healthy individuals who are not in hospitals or nursing homes and do not have significant underlying medical conditions. Communities are not allowing the fungus to spread freely. It’s not in the air. It is unlikely to be found in a school or grocery store. Those with weakened immune systems, blood cancers, diabetes, or those who depend on invasive medical devices during extended hospital stays should be the most concerned.
Nevertheless, it is difficult to ignore the rate of spread. Positive screening cultures in the United States doubled from about 6,000 to 12,000 between 2022 and 2024. That trajectory was deemed concerning by UC Irvine experts. Since many people carry C. auris without any symptoms at all and would never know if they weren’t tested, it’s possible that the actual number of carriers is higher than reported.
Here, there is a more general pattern that is worth observing. For many years, antimicrobial resistance in bacteria and fungi has been a slow-moving medical concern. One of its more noticeable recent manifestations seems to be Candida auris. In the early 2010s, it first appeared, spread nearly simultaneously across four continents, and has been steadily increasing ever since. Why it appeared so quickly and in so many locations at once is still a mystery to scientists. It’s worth taking a moment to sit with that uncertainty alone.
The practical lesson for most people reading this at home is straightforward: ask about C. auris screening if you or someone you know is in a high-risk medical setting, and wash your hands carefully when visiting anyone in a hospital or care facility. Although raising awareness is the first step in prevention, it won’t completely remove the risk.
